Abstract B26: [Advocate Abstract:] We all win

To gain long-term survivorship joint interest among the survivor-patient, family-spouse, children, siblings, friends, with an engaging medical community that creates trust for both patient and family are keys to long-term success. After treatment has completed, do both patient and family members understand that long-term success depends on continued follow-up? I have observed that patients after initial treatment make a conscious decision to curtail medical treatment. Cost and quality of life along with no longer wanting to be a burden to patients9 family are key issues. The prostate survivor when still with the family is a gift that strengthens the family and is priceless. Continually turning to the medical community after treatment enhances life. Another issue is patients who are 5 years and beyond with their treatment who have health concerns that in part can be related to cancer therapies. These patients choose watchful waiting. We as Health Advocates have to promote continued health care to post-treated patients. We have to nurture and foster families that what is good for Dad is good for them. Citation Format: Frank D. Fields. [Advocate Abstract:] We all win [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr B26.